SPDR S&P Pharmaceuticals ETF
Health/Biotechnology
XPH
One Iron Street,
Boston , MA, 02210
Boston , MA, 02210
Price
-
$ 43.25
0 %
-0.24
Dec 19, 2024
- Last Close
- Net Assets
-
$222.6M
Feb 27, 2024
- 52-Week High/Low
- $48.29 - $39.09
- Expense Ratio
- -
Link
Directors
Sep 12, 2023- Sandra G. Sponem
- Dwight D. Churchill
- Gunjan Chauhan
- Carolyn M. Clancy
- Carl G. Verboncoeur
- James E. Ross
- Clare S. Richer
- Kristi L. Rowsell
Chief Compliance Officer
- Brian Harris
Company Name |
Holding |
| More | 0.08 % |
Documents
Returns +
Q
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Q1 | 3.6% | 0.2% | -0.8% | -3.5% | -21% | 13.7% |
| Q2 | -1.5% | -0.1% | -7.2% | 4% | 19.2% | -4.4% |
| Q3 | - | -3% | -4.4% | -9.8% | 0.8% | -11% |
| Q4 | - | 6.2% | 2% | -2.3% | 19.1% | 27.7% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 0.9% | 5.8% | -2.9% | -7.7% | 1.3% | - | - | - | - | - | - | - |
| 2023 | 6.3% | -5.2% | -0.7% | 2.6% | -6.2% | 3.9% | 6.7% | -0% | -9.1% | -9.9% | 3.3% | 12.5% |
Returns +
A
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.2% | 1.6% | -10.3% | -11.5% | 13% | 24.9% | -15.3% | 12% | -23.2% | 1.7% | 36.5% |